Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Octreotide may stop or slow the growth of tumor cells and may be an effective
treatment for liver cancer.
PURPOSE: This phase II trial is studying how well octreotide works in treating patients with
locally advanced or metastatic liver cancer.